SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abionyx Pharma Finalizes Manufacturing Process for Recombinant Human ApoA-I

Abionyx Pharma finalized an end-to-end manufacturing process for recombinant human ApoA-I with Axplora.

Related stories